PEZA: Indian firm planning to set up PH facilty

By Janine Alexis Miguel

Sep 30, 2024 12:10 am

INDIAN pharmaceutical firm Aurobindo Pharma Ltd. plans to establish a facility in the Philippines to manufacture generic pharmaceuticals and active pharmaceutical ingredients (APIs), the Philippine Economic Zone Authority (PEZA) said last week.

PEZA Director General Tereso Panga met with Aurobindo Pharma's Chief Business Officer Ravikiran Namburi, Senior Vice President Debashis Sarkar, and General Manager Aravind Babu at the PEZA head office last September 26, following a July 2024 meeting in India.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Manila Water secures P15-B loan for projects

Globe: 19 more towers sold to Unity for P228M

Victorias Milling nets P1.55B in fiscal year

ICTSI unit's Mindanao terminal concession extended by Phividec

SM Prime seeks SEC OK for P25-B offering

P12-B bond offering eyed by Filinvest Land

ACEN unit wins Australia power project